Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00457678
What this trial is testing

Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

Who this might be right for
Age Related Macular Degeneration
Vitreous -Retina- Macula Consultants of New York
Early research (Phase 1)Active Not RecruitingNCT06825858
What this trial is testing

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04657289
What this trial is testing

The Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 451
Not applicableEnded earlyNCT02625376
What this trial is testing

Resveratrol for Exudative Age-Related Macular Degeneration

Who this might be right for
AMDAge-related Macular DegenerationChoroidal Neovascularisation
Poitiers University Hospital 25
Not applicableEnrolling By InvitationNCT07660640
What this trial is testing

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

Who this might be right for
Age-Related Macular Degeneration (AMD)Non-Neovascular Age-Related Macular Degeneration
Perceive Biotherapeutics, Inc. 88
Large-scale testing (Phase 3)Looking for participantsNCT06996080
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Who this might be right for
Macular Edema Secondary to Inflammation
Kodiak Sciences Inc 300
Not applicableStudy completedNCT00342251
What this trial is testing

Investigating Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 3,000
Not applicableEnrolling By InvitationNCT07747662
What this trial is testing

Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study

Who this might be right for
Geographic Atrophy
University of Wisconsin, Madison 10
Testing effectiveness (Phase 2)Study completedNCT04085341
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Diabetic Macular EdemaRetina Vein Occlusion
Graybug Vision 21
Testing effectiveness (Phase 2)Study completedNCT02732951
What this trial is testing

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

Who this might be right for
Macular Edema
Boehringer Ingelheim 105
Testing effectiveness (Phase 2)Study completedNCT01331005
What this trial is testing

NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 125
Not applicableLooking for participantsNCT06805474
What this trial is testing

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

Who this might be right for
Macular DegenerationGeographic AtrophyStargardt Disease
Nanoscope Therapeutics Inc. 30
Not applicableLooking for participantsNCT07019896
What this trial is testing

Minimal Vitrectomy Surgery for Epiretinal Membrane

Who this might be right for
Epiretinal MembraneMacular Edema (ME)Nuclear Cataract
Peking Union Medical College Hospital 140
Not applicableStudy completedNCT04395859
What this trial is testing

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

Who this might be right for
Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Fondation Ophtalmologique Adolphe de Rothschild 233
Not applicableStudy completedNCT02464956
What this trial is testing

Production of iPSC Derived RPE Cells for Transplantation in AMD

Who this might be right for
Age Related Macular Degeneration (AMD)
Moorfields Eye Hospital NHS Foundation Trust 3
Not applicableStudy completedNCT01542866
What this trial is testing

A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration (AMD)
Novartis Pharmaceuticals 160
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Large-scale testing (Phase 3)Study completedNCT05345236
What this trial is testing

Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Qilu Pharmaceutical Co., Ltd. 366
Not applicableStudy completedNCT01918371
What this trial is testing

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 323
Early research (Phase 1)Study completedNCT05105607
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 16
Next Page